Probabilistic sensitivity analysis for decision trees with multiple branches: Use of the Dirichlet distribution in a Bayesian framework

被引:145
作者
Briggs, AH [1 ]
Ades, AE
Price, MJ
机构
[1] Univ Oxford, Inst Hlth Sci, Hlth Econ Res Ctr, Oxford OX3 7LF, England
[2] Univ Bristol, MRC, Hlth Serv Res Collaborat, Bristol, Avon, England
[3] Janssen Cilag Ltd, Saunderton, England
关键词
probabilistic sensitivity analysis; decision; models; Dirichlet distribution;
D O I
10.1177/0272989X03255922
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In structuring decision models of medical interventions, it is commonly recommended that only 2 branches be used for each chance node to avoid logical inconsistencies that can arise during sensitivity analyses if the bran ching probabilities do not sum to 1. However, information may be naturally available in an unconditional form, and structuring a tree in conditional form may complicate rather than simplify the sensitivity analysis of the unconditional probabilities. Current guidance emphasizes using probabilistic sensitivity analysis, and a method is required to provide probabilistic probabilities over multiple branches that appropriately represents uncertainty while satisfying the requirement that mutually exclusive event probabilities should sum to 1. The authors argue that the Dirichlet distribution, the multivariate equivalent of the beta distribution, is appropriate for this purpose and illustrate its use for generating a fully probabilistic transition matrix for a Markov model. Furthermore, they demonstrate that by adopting a Bayesian approach, the problem of observing zero counts for transitions of interest can be overcome.
引用
收藏
页码:341 / 350
页数:10
相关论文
共 24 条
  • [1] Markov chain Monte Carlo estimation of a multiparameter decision model: Consistency of evidence and the accurate assessment of uncertainty
    Ades, AE
    Cliffe, S
    [J]. MEDICAL DECISION MAKING, 2002, 22 (04) : 359 - 371
  • [2] Akehurst R, 2000, PHARMACOECONOMICS, V17, P443
  • [3] [Anonymous], 2002, MODELING MED DECISIO
  • [4] [Anonymous], 1996, COST EFFECTIVENESS H
  • [5] THE MARKOV PROCESS IN MEDICAL PROGNOSIS
    BECK, JR
    PAUKER, SG
    [J]. MEDICAL DECISION MAKING, 1983, 3 (04) : 419 - 458
  • [6] Probabilistic analysis of cost-effectiveness models: Choosing between treatment strategies for gastroesophageal reflux disease
    Briggs, AH
    Goeree, R
    Blackhouse, G
    O'Brien, BJ
    [J]. MEDICAL DECISION MAKING, 2002, 22 (04) : 290 - 308
  • [7] Primer on medical decision analysis .2. Building a tree
    Detsky, AS
    Naglie, G
    Krahn, MD
    Redelmeier, DA
    Naimark, D
    [J]. MEDICAL DECISION MAKING, 1997, 17 (02) : 126 - 135
  • [8] Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205
  • [9] Eddy D M, 1990, Int J Technol Assess Health Care, V6, P31
  • [10] FLEMING C, 1987, MED DECIS MAKING, V7, P281